Crestwood Advisors Group LLC Takes Position in HealthEquity, Inc. (NASDAQ:HQY)

Crestwood Advisors Group LLC purchased a new stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The fund purchased 12,762 shares of the company's stock, valued at approximately $1,128,000.

Several other hedge funds and other institutional investors have also modified their holdings of the business. T. Rowe Price Investment Management Inc. bought a new stake in shares of HealthEquity during the 4th quarter worth about $78,107,000. Norges Bank bought a new stake in shares of HealthEquity during the 4th quarter worth about $74,701,000. Raymond James Financial Inc. bought a new stake in shares of HealthEquity during the 4th quarter worth about $45,728,000. Iron Triangle Partners LP bought a new stake in shares of HealthEquity during the 4th quarter worth about $32,202,000. Finally, Artisan Partners Limited Partnership bought a new stake in shares of HealthEquity during the 4th quarter worth about $24,568,000. 99.55% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

HQY has been the topic of several recent research reports. Barrington Research lifted their price objective on shares of HealthEquity from $112.00 to $125.00 and gave the stock an "outperform" rating in a research note on Thursday, June 5th. Raymond James Financial restated a "strong-buy" rating and set a $120.00 price target (up previously from $115.00) on shares of HealthEquity in a report on Tuesday, July 8th. JMP Securities boosted their price target on shares of HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a report on Wednesday, June 4th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a report on Thursday, June 5th. Finally, Royal Bank Of Canada boosted their price target on shares of HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a report on Wednesday, June 4th. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Buy" and an average price target of $118.55.

HealthEquity Stock Up 0.3%

HealthEquity stock opened at $97.41 on Wednesday. The company's 50 day simple moving average is $101.67 and its 200 day simple moving average is $98.48. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $116.65. The firm has a market capitalization of $8.42 billion, a price-to-earnings ratio of 71.10, a PEG ratio of 1.50 and a beta of 0.49. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. The firm had revenue of $330.80 million for the quarter, compared to analyst estimates of $322.25 million. During the same quarter in the previous year, the firm posted $0.80 earnings per share. As a group, sell-side analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insider Buying and Selling at HealthEquity

In related news, EVP Michael Henry Fiore sold 1,794 shares of the company's stock in a transaction dated Monday, July 7th. The shares were sold at an average price of $101.73, for a total value of $182,503.62. Following the transaction, the executive vice president directly owned 53,225 shares in the company, valued at approximately $5,414,579.25. This represents a 3.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Jon Kessler sold 134,183 shares of the company's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $112.08, for a total transaction of $15,039,230.64. Following the completion of the transaction, the director owned 253,510 shares in the company, valued at $28,413,400.80. This trade represents a 34.61% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 291,744 shares of company stock worth $32,705,007 over the last ninety days. Insiders own 1.50% of the company's stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.